Align Technology, Inc.

ALGN Healthcare Medical Instruments & Supplies

Align Technology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 0.90% from fiscal 2024.

Revenue
+1.92%
EPS
+143.9%
Free cash flow
+8.26%

Quarter to September 2026, against a year earlier

160.79 1.42 +0.89%
Market cap
$11.3B
P/E
23.1×
Fwd P/E
20.4×
Dividend yield
—
F-score
6/9
Altman Z
4.73
Beneish M
−2.52
Dividend safety
n/a
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
ROE
0.00% 10.16% 10.82% 10.39%

+8 more TTM periods

Piotroski F-Score
9 7 8 6
ROA
7.71% 6.55% 6.92% 6.59%
ROIC
12.27% 10.93% 11.26% 11.55%
Return on Tangible Assets
25.26% 22.13% 23.14% 22.45%
Average Days of Receivables
102.15 101.26 100.27 99.66
Free Cash Flow per Share
10.56 9.45 8.17 6.77
Free Cash Flow
749.89 675.57 583.65 490.78
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026